Review



dx® eplex® sars-cov-2 test  (GenMark Diagnostics)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    GenMark Diagnostics dx® eplex® sars-cov-2 test
    Dx® Eplex® Sars Cov 2 Test, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dx%C2%AE+eplex%C2%AE+sars-cov-2+test/eplex+sars+cov+2+test/pmc11795984-60-13-28
    Average 90 stars, based on 1 article reviews
    dx® eplex® sars-cov-2 test - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Control:

    Article Title: Effectiveness of SARS‐CoV‐2 testing strategies: A scoping review
    Article Snippet: [ ] , RT‐PCR [Cobas Liat SARS‐CoV‐2 and Influenza A/B (intervention period)] , RT‐PCR [Cobas SARS‐CoV‐2 test on the cobas 6800 System or on‐demand urgent testing using the GenMark Dx® ePlex® SARS‐CoV‐2 Test (control period)] , SARS‐CoV‐2 positivity rate: ‐ RT‐PCR (Cobas Liat SARS‐CoV‐2 and Influenza A/B) 14.05% ‐ RT‐PCR (Cobas SARS‐CoV‐2 test on the cobas 6800 System) 12.4% Cases: ‐ RT‐PCR (Cobas Liat SARS‐CoV‐2 and Influenza A/B) 638 ‐ RT‐PCR (Cobas SARS‐CoV‐2 test on the cobas 6800 System) 538 Hospitalization: ‐ RT‐PCR (Cobas Liat SARS‐CoV‐2 and Influenza A/B) 38.33% ‐ RT‐PCR (Cobas SARS‐CoV‐2 test on the cobas 6800 System) 36.32% ICU admission rate: ‐ RT‐PCR (Cobas Liat SARS‐CoV‐2 and Influenza A/B) 11.78% ‐ RT‐PCR (Cobas SARS‐CoV‐2 test on the cobas 6800 System) 14.22% Death: ‐ RT‐PCR (Cobas Liat SARS‐CoV‐2 and Influenza A/B) 0.16% ‐ RT‐PCR (Cobas SARS‐CoV‐2 test on the cobas 6800 System) 0.16%.

    Real-time Polymerase Chain Reaction:

    Article Title: Effectiveness of SARS‐CoV‐2 testing strategies: A scoping review
    Article Snippet: [ ] , RT‐PCR [Cobas Liat SARS‐CoV‐2 and Influenza A/B (intervention period)] , RT‐PCR [Cobas SARS‐CoV‐2 test on the cobas 6800 System or on‐demand urgent testing using the GenMark Dx® ePlex® SARS‐CoV‐2 Test (control period)] , SARS‐CoV‐2 positivity rate: ‐ RT‐PCR (Cobas Liat SARS‐CoV‐2 and Influenza A/B) 14.05% ‐ RT‐PCR (Cobas SARS‐CoV‐2 test on the cobas 6800 System) 12.4% Cases: ‐ RT‐PCR (Cobas Liat SARS‐CoV‐2 and Influenza A/B) 638 ‐ RT‐PCR (Cobas SARS‐CoV‐2 test on the cobas 6800 System) 538 Hospitalization: ‐ RT‐PCR (Cobas Liat SARS‐CoV‐2 and Influenza A/B) 38.33% ‐ RT‐PCR (Cobas SARS‐CoV‐2 test on the cobas 6800 System) 36.32% ICU admission rate: ‐ RT‐PCR (Cobas Liat SARS‐CoV‐2 and Influenza A/B) 11.78% ‐ RT‐PCR (Cobas SARS‐CoV‐2 test on the cobas 6800 System) 14.22% Death: ‐ RT‐PCR (Cobas Liat SARS‐CoV‐2 and Influenza A/B) 0.16% ‐ RT‐PCR (Cobas SARS‐CoV‐2 test on the cobas 6800 System) 0.16%.



    Similar Products

    dx® eplex® sars-cov-2 test  (GenMark Diagnostics)
    90
    GenMark Diagnostics dx® eplex® sars-cov-2 test
    Dx® Eplex® Sars Cov 2 Test, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dx%C2%AE+eplex%C2%AE+sars-cov-2+test/eplex+sars+cov+2+test/pmc11795984-60-13-28
    Average 90 stars, based on 1 article reviews
    dx® eplex® sars-cov-2 test - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    dx eplex® sars-cov-2 test  (GenMark Diagnostics)
    90
    GenMark Diagnostics dx eplex® sars-cov-2 test
    Selected commercial nucleic acid-based point-of-care tests (ordered by time to result).
    Dx Eplex® Sars Cov 2 Test, supplied by GenMark Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dx%C2%AE+eplex%C2%AE+sars-cov-2+test/eplex+sars+cov+2+test/pmc07202255-11-1-0
    Average 90 stars, based on 1 article reviews
    dx eplex® sars-cov-2 test - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Selected commercial nucleic acid-based point-of-care tests (ordered by time to result).

    Journal: Frontiers in Cellular and Infection Microbiology

    Article Title: Current and Future Point-of-Care Tests for Emerging and New Respiratory Viruses and Future Perspectives

    doi: 10.3389/fcimb.2020.00181

    Figure Lengend Snippet: Selected commercial nucleic acid-based point-of-care tests (ordered by time to result).

    Article Snippet: (GenMark Dx ePlex® SARS-CoV-2 Test, ) Test , rRT-PCR/ <120 , N/A , N/A , • , N/A , N/A , N/A , N/A , N/A , N/A , N/A.

    Techniques: Luminex